Hemera receives the Seal of Excellence from the European Commission for the REMaST project

Jul 15, 2025 | News

Hemera recently participated in the prestigious European program EIC Accelerator, promoted by the European Commission to support high-impact technological innovation on an international scale. Our application focused on the REMaST project, First Regenerative Medicine...

European Patent Granted for REMaST: a Key Step in Enhancing Hemera’s Intellectual Property

Jun 11, 2025 | News

The European patent for REMaST, Hemera’s proprietary technology for nervous tissue regeneration, has been published in Issue 24/25 of the European Patent Office (EPO) Bulletin on June 11, 2025https://www.epo.org/bulletin/downloads/2025/bulletin2524.pdf. The patent...

We warmly welcome Statuto Fiduciaria among Hemera’s supporters

May 15, 2025 | News

We are pleased to announce the entry of Statuto Fiduciaria as a new shareholder, representing the subscribers of the SAFE – Simple Agreement for Future Equity – which has reached €500,000. This transaction confirms the strong interest in the Hemera project from...

Hemera goes to Brussels for the Final Phase of the EIC Accelerator

May 13, 2025 | News

Hemera is among the 7 Italian startups out of 71 selected across Europe, that successfully passed the second phase of the EIC Accelerator selection process, the prestigious European Union program supporting highly innovative SMEs and startups. Hemera has now received...

Hemera at the Chamber of Deputies to Receive the 2025 America Innovation Award

Apr 7, 2025 | Events, News

Hemera has been selected among 300 Italian entrepreneurial ventures as a recipient of the America Innovation Award, promoted by the Italy–USA Foundation and presented at the Chamber of Deputies in Rome. The award is dedicated to Italian startups and SMEs that have...

Research by Hemera Scientists on Nature Immunology Review

Mar 28, 2025 | News

The study titled “Tumor-associated macrophages enhance tumor innervation and spinal cord repair”, to which our researchers contributed, was recently published by Nature Reviews Immunology—one of the most authoritative journals in the field of immunology and a global...